Related Experiment Videos

[Cryptococcosis. A study of 9 strains of Cryptococcus neoformans isolated from immunodeficient patients]

G Nobre1, M O Ramalho, E Mendes

  • 1Instituto Bacteriológico Cămara Pestana, Hospital Curry Cabral, Lisboa.

Insights

This study investigated Cryptococcus neoformans strains from AIDS patients, finding variations in antifungal susceptibility, particularly to 5-fluorocytosine, despite similar morphology. All strains remained pathogenic in mice.

Area of Science:

  • Mycology
  • Infectious Diseases
  • AIDS Research

Background:

  • Cryptococcus neoformans is an opportunistic fungal pathogen.
  • AIDS patients are particularly susceptible to Cryptococcus neoformans infections.
  • Understanding fungal strain characteristics is crucial for effective treatment.

Purpose of the Study:

  • To characterize Cryptococcus neoformans strains isolated from AIDS patients.
  • To evaluate the in vitro antifungal susceptibility profiles of these strains.
  • To assess the pathogenicity of these strains in a murine model.

Main Methods:

  • Isolation and identification of Cryptococcus neoformans from cerebrospinal fluid and blood samples.
  • Auxanographic typing to differentiate strains.
  • Pathogenicity testing in mice via intracerebral inoculation.
  • Antifungal susceptibility testing against 5-fluorocytosine and other agents.

Main Results:

  • Nine Cryptococcus neoformans strains were isolated from AIDS patients.
  • Strains exhibited identical morphology but varied auxanographic patterns.
  • All isolates were pathogenic in the murine intracerebral model.
  • Six strains were susceptible to 5-fluorocytosine, while three were resistant.
  • All strains demonstrated susceptibility to nystatin, amphotericin B, clotrimazole, miconazole, econazole, and ketoconazole.

Conclusions:

  • Cryptococcus neoformans strains from AIDS patients display heterogeneity in antifungal susceptibility, specifically to 5-fluorocytosine.
  • Morphological similarity does not preclude differences in auxanotyping and drug resistance.
  • These findings highlight the importance of susceptibility testing for guiding antifungal therapy in immunocompromised patients.

Related Concept Videos